Therefore, our work shed light on a mechanism that SETD2 deficiency would exert a crucial impact on SM-mediated biochemical functions and ultimately facilitate the transition from PKD to ccRCC. The gene discussed is SETD2; the disease is nonpapillary renal cell carcinoma.